Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-09-19
2006-09-19
Nazario-Gonzalez, Porfirio (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C548S403000, C548S523000, C548S524000, C549S355000, C549S429000, C549S510000, C556S136000, C556S466000, C562S433000, C562S553000, C562S590000, C564S336000, C564S340000, C502S166000, C502S167000
Reexamination Certificate
active
07109343
ABSTRACT:
Compounds having the formula:are disclosed. M1and M2are the same or different and are transition metal atoms or ions; Z2and Z3, independently, are the atoms necessary to complete a 3–12 membered heterocyclic ring; Z1is an alkylene or arylene group; Q1and Q2are the same or different and are electron withdrawing groups; L1and L3, taken together, represent —O—CR13—O—; L2and L4, taken together, represent —O—CR14—O—; and R13and R14are the same or different and are selected from the group consisting of alkyl groups and aryl groups or R13and R14represent alkylene or arylene groups that are directly or indirectly bonded to one another. Methods for making such compounds are also disclosed, as are intermediates which can be used in their preparation. Also disclosed are methods for carrying out C—H insertion reactions using bis-transition metal catalysts, such as the above compounds. Procedures for preparing d-threo methylphenidate, tolterodine, CDP-840, nominfensine, and sertraline, are described.
REFERENCES:
patent: 2507631 (1950-05-01), Hartmann et al.
patent: 2957880 (1960-10-01), Rometsch et al.
patent: 4133881 (1979-01-01), Cale, Jr. et al.
patent: 4238488 (1980-12-01), Howe et al.
patent: 4866048 (1989-09-01), Calverley et al.
patent: 5036053 (1991-07-01), Himmelsbach et al.
patent: 5296595 (1994-03-01), Doyle
patent: 5401732 (1995-03-01), Calverley et al.
patent: 5665890 (1997-09-01), Jacobsen et al.
patent: 6025502 (2000-02-01), Winklter et al.
patent: 6410746 (2002-06-01), Davies
patent: 6762304 (2004-07-01), Davies
patent: 2 260 903 (1993-05-01), None
patent: WO 96/28250 (1996-09-01), None
Deutsch et al., “Synthesis and Pharmacology of Potential Cocaine Antagonists, 2. Structure—Activity Relationship Studies of Aromatic Ring-Substituted Methylphenidate Analogs,”J. Med. Chem., 39:1201-1209 (1996).
Doyle et al., “Chiral Catalysts for Enantioselective Intermolecular Cyclopropanation Reactions With Methyl Phenyldiazoacetate. Origin of the Solvent Effect in Reactions Catalyzed by Homochiral Dirhodium(II) Prolinates,”Terrahedron Letters, 37(24):4129-4132 (1996).
Davies et al., “Asymmetric Intermolecular Carbenoid C-H Insertions Catalyzed by Rhodium(II) (S)-N-(p-Dodecylphenyl)sulfonylprolinate,”J. Am. Chem. Soc., 119:9075-9076 (1997).
Davies, “Asymmetric Synthesis Using Rhodium-Stabilized Vinylcarbenoid Intermediates,”Aldrichimica Acta, 30(4):107-114 (1997).
Davies et al., “Enantioselective Synthesis of Functionalized Tropanes by Rhodium (II) Carboxylate-Catalyzed Decomposition of Vinyldiazomethanes in the Presence of Pyrroles,”J. Org. Chem., 62:1095-1105 (1997).
Davies et al., “Synthesis and Evaluation of a Novel Dirhodium Tetraprolinate Catalyst Containing Bridging Prolinate,”Tetrahedron Letters, 38(24):4203-4206 (1997).
Axten et al., “A Stereoselective Synthesis of dl-threo-Methylphenidate: Preparation and Biological Evaluation of Novel Analogues,”J. Org. Chem., 63:9628-9629 (1998).
Davies et al., “Effect of Carbenoid Structure on the Reactivity of Rhodium Stabilized Carbenoids,”Tetrahedron Letters, 39:4417-4420 (1998).
Davies, “Rhodium-Stabilized Vinylcarbenoid Intermediates in Organic Synthesis,”Current Organic Chemistry, 2:463-488 (1998).
Stinson, “Counting on Chiral Drugs,”Chemical&Engineering News, pp. 83ff (Sep. 21. 1998).
Thai et al., “Asymmetric Synthesis and Pharmacology of Methylphenidate and Its Para-Substituted Derivatives,”J. Med. Chem., 41:591-601 (1998).
Axten et al., “Enantioselective Synthesis of D-threo-Methylphenidate,”J. Am. Chem Soc., 121(27):6511-6512 (1999).
Davies et al., “Catalytic Asymmetric Synthesis of Diarylacetates and 4,4-Diarylbutanoates. A Formal Asymmetric Synthesis of (+)-Sertraline,”Organic Letters, 1(2):233-236 (1999).
Davies et al., “Catalytic Asymmetric Synthesis of Syn-Aldol Products from Intermolecular C-H Insertions Between Allyl Silyl Esthers and Methyl Aryldiazoacetates,”Organic Letters, 1(3):383-385 (1999).
Davies, “Dirhodium Tetra(N-arylsulfonylprolinates) as Chiral Catalysts For Asymmetric Transformations of Vinyl- and Aryldiazoacetates,”Eur. J. Org. Chem., 2459-2469 (1999).
Davies et al., “Highly Regio-, Diastereo-, and Enantioselective C-H Insertions of Methyl Aryldiazoacetates into Cyclic N-Boc-Protected Amines. Asymmetric Synthesis of Novel C2-Symmetric Amines and threo-Methylphenidate,”J. Am. Chem Soc., 121(27):6509-6510 (1999).
Davies et al., “Novel Dirhodium Tetraprolinate Catalysts Containing Bridging Prolinate Ligands for Asymmetric Carbenoid Reactions,”Tetrahedron Letters, 40:5287-5290 (1999).
Deutsch et al., “Synthesis and Pharmacology of Site-Specific Cocaine Abuse Treatment Agents: 2-(Aminomethyl)-3-phenylbicyclo[2.2.2]- and-[2.2.1]alkane Dopamine Uptake Inhibitors,”J. Med. Chem., 42:882-895 (1999).
Deutsch et al., “Synthesis and Pharmacology of Site-Specific Cocaine Abuse Treatment Agents: The Role of the Phenyl Group in Highly Modified Methylphenidate Analogs as Dopamine Uptake Inhibitors,”Med. Chem. Res., 9(4):213-222 (1999).
Matsumura et al., “A Convenient Method for Synthesis of Enantiomerically Enriched Methylphenidate from N-Methoxycarbonylpiperidine,”Organic Letters, 1(2):175-178 (1999).
Prashad et al., “Enantioselective Synthesis of (2S,2′R)-erythro-methylphenidate,”Tetrahedron: Asymmetry, 10:3479-3482 (1999).
Prashad et al., “The First Enantioselective Synthesis of (2R,2′R)-threo-(+)-Methylphenidate Hydrochloride,”J. Org. Chem., 64:1750-1753 (1999).
Davies et al., “Stereoselectivity of Methyl Aryldiazoacetate Cyclopropanations of 1,1-Diarylethylene. Asymmetric Synthesis of a Cyclopropyl Analogue of Tamoxifen,”Organic Letters, 2(6):823-826 (2000).
Davies et al., “Catalytic Asymmetric Synthesis of Diarylacetates and 4,4-Diarylbutanoates. A Formal Asymmetric Synthesis of (−)-Sertraline,”Organic Letters, 2(3):417 (2000).
Nazario-Gonzalez Porfirio
Rogalskyj & Weyand LLP
The Research Foundation of State University of New York
LandOfFree
Metal catalysts and methods for making and using same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Metal catalysts and methods for making and using same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metal catalysts and methods for making and using same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3588123